493
Views
8
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

The impact of residential medication management reviews (RMMRs) on medication regimen complexity

, , , ORCID Icon, &
Pages 575-579 | Received 20 Feb 2018, Accepted 16 Jul 2018, Published online: 09 Aug 2018
 

ABSTRACT

Objectives: The primary objective of this study was to investigate the impact of RMMRs on medication regimen complexity, as assessed by a validated measure.

Methods: Retrospective analysis of RMMRs pertaining to 285 aged care residents aged ≥ 65 years in Sydney, Australia. Medication regimen complexity was measured using the Medication Regimen Complexity Index (MRCI) at baseline, after pharmacists’ recommendations (assuming that all of the pharmacists’ recommendations were accepted by the General Practitioner (GP)), and after the actual uptake of pharmacists’ recommendations by the GP. Differences in the regimen complexity was measured using the Wilcoxon sign rank test.

Results: Pharmacists made 764 recommendations (average 2.7 recommendations per RMMR), of which 569 (74.5%) were accepted by GPs. The median MRCI at baseline in the sample was 25.5 (IQR = 19.0–32.5). No statistically significant differences were demonstrated in the MRCI scores after pharmacists’ recommendations (p = 0.53) or after GPs’ acceptance of these recommendations (p = 0.07) compared to the baseline.

Conclusion: Our study revealed high acceptance of pharmacists’ recommendations by GPs. This suggests that RMMRs are useful for identifying and resolving drug-related issues among residents of ACFs. However, our study failed to show a significant effect of RMMRs in reducing the medication regimen complexity, as measured by the MRCI. Further studies are needed to establish the association of medication regimen complexity and clinical outcomes in residents of ACFs.

Acknowledgments

The authors acknowledge Meditrax Pty Ltd and staff for providing de-identified medication reviews used in this study.

Declaration of interest

Prasad Nishtala is a former employee of Meditrax. Paul Hannan is a Consultant for Meditrax. Mahsa Pouranayatihosseinabad, Syed Tabish R Zaidi, Gregory Peterson, Prasad Nishtala, Paul Hannan, and Ronald Castelino have no potential conflicts of interests that are directly relevant to the content of this study. PGM peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

No sources of funding were used to assist in this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.